Institutional investors control 48.31% of the outstanding shares in GERN. This represents a greater percentage of ownership than at almost any other company in the Biotechnology industry. Additionally, during the quarter ended June 2015, these large investors purchased a net $13.8 million shares.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
CREDIT SUISSE AG Bought 7.0 Thousand shares of Geron Corp
STATE STREET GLOBAL ADVISORS LTD... Bought 423.00 shares of Geron Corp
LIFESCI INDEX PARTNERS LLC Sold 5.2 Thousand shares of Geron Corp